Table 3

Immunologic and clinical response

UPNNo. of vaccinationsDetectable immune responseDisease-free survival, moOverall survival, moStatus
+CD4; +DTH 18 R-D 
2* +CD8 12 20 R-D 
+CD4 10 35 R-D 
4* 5 +CD4; +CD8 40+ 41+ CCR 
5* 8 +DTH; +CD4; +CD8 35+ 36+ CCR 
12 +CD4 31+ 33+ CCR 
None 10 23 R-D 
12 +CD4 32+ 34+ CCR 
12 +CD4 31+ 33+ CCR 
UPNNo. of vaccinationsDetectable immune responseDisease-free survival, moOverall survival, moStatus
+CD4; +DTH 18 R-D 
2* +CD8 12 20 R-D 
+CD4 10 35 R-D 
4* 5 +CD4; +CD8 40+ 41+ CCR 
5* 8 +DTH; +CD4; +CD8 35+ 36+ CCR 
12 +CD4 31+ 33+ CCR 
None 10 23 R-D 
12 +CD4 32+ 34+ CCR 
12 +CD4 31+ 33+ CCR 

UPN indicates unique patient number; +CD4, positive CD4 response; +DTH, positive delayed hypersensitivity response; +CD8, positive CD8 response; R-D, relapse dead; and CCR, continuous complete remission.

*

HLA-A0201 patient.

Taken off study because of hypersensitivity to vaccine/adjuvant.

or Create an Account

Close Modal
Close Modal